This marks only the third time since 1998 that national authorities have systematically employed fiscal tools to shore up core Tier 1 capital for financial institutions. The previous two rounds targeted state-owned commercial banks, but this initiative broadens the scope for the first time to encompass policy banks and state-owned commercial insurers.

Following the 500 billion yuan injection in 2025, the second wave of special treasury bond funding for central financial enterprises has officially taken shape. On September 6, eight central financial entities announced plans to raise a combined 360 billion yuan through private placements and direct capital injections. The Ministry of Finance will contribute 300 billion yuan via special treasury bonds, while China National Tobacco Corporation and its affiliates will provide 60 billion yuan. The recipients include major state-owned banks, state-owned commercial insurers, and policy banks.

Industrial and Commercial Bank of China (601398.SH, 1398.HK) and Agricultural Bank of China (601288.SH, 1288.HK) intend to raise up to 100 billion yuan and 160 billion yuan, respectively, with the Ministry of Finance subscribing for 70 billion yuan and 130 billion yuan of those amounts. Meanwhile, China Life Insurance Group (601628.SH, 2628.HK), PICC Group (601319.SH, 1339.HK), China Taiping (0966.HK), and China Reinsurance Group (1508.HK) will raise 35 billion yuan, 15 billion yuan, 7 billion yuan, and 3 billion yuan, respectively, all fully funded by the Ministry of Finance through special treasury bonds, totaling 60 billion yuan. Additionally, Export-Import Bank of China and Sinosure will receive direct injections of 30 billion yuan and 10 billion yuan, respectively.

The two earlier rounds were tied to non-performing loan resolution and shareholding reform listings. This latest effort, however, comes as narrowing interest margins weaken internal capital generation, TLAC (Total Loss-Absorbing Capacity) regulations approach their deadline, and fiscal expansion accelerates capital consumption鈥攎aking it a forward-looking move to proactively strengthen capital buffers, according to China Chengxin Analytics.

Capital injections for the major state-owned banks had long been anticipated. Back in 2024, the Ministry of Finance signaled it would issue special treasury bonds to support capital replenishment at large state-owned commercial banks, guided by a principle of coordinated planning, phased execution, and tailored approaches for each institution. In 2025, China Construction Bank, Bank of China, Bank of Communications, and Postal Savings Bank of China completed their capital enhancements. The 2026 government work report then proposed issuing 300 billion yuan in special treasury bonds to further support this effort.

China Chengxin Analytics notes that bank capital remains the absolute focus of this round. Based on its estimates, the core Tier 1 capital adequacy ratios for ICBC and ABC could be bolstered by approximately 33 and 61 basis points, respectively, potentially unlocking around 2.43 trillion yuan in lending capacity. However, with credit demand currently subdued, this capital is more likely to be channeled into bond purchases rather than aggressive loan growth.

This marks the first time state-owned insurance giants have been brought into the special treasury bond injection framework. Wang Guojun, a professor at the University of International Business and Economics' School of Insurance, views the move as a way to strengthen the core capital of these insurers and counter the capital consumption pressures of a low-interest-rate environment. He stresses that this is not a stock market rescue measure; the supported insurers already maintain sound solvency levels, and the funding is meant to reinforce their positions preemptively rather than bail them out. The capital is designated for institutional strengthening, not direct equity purchases, and the long lock-up periods for private placements mean no additional supply pressures on the secondary market. The overarching goal is to solidify the financial system's foundation and support the real economy, not to prop up share prices.

Li Qiusuo, chief domestic strategy analyst at CICC Research, adds that stronger capital positions for major state-owned banks and insurance groups will enhance the operational stability of China's financial institutions. Given that many of the involved companies are heavyweight A-share constituents, this development is likely to boost investor confidence and improve capital market stability.

Notably, on September 7, share prices for six listed financial central enterprises generally declined. China Taiping and China Reinsurance Group each fell over 3% in a single day, while H-shares of ICBC and ABC dropped more than 2%. China Life and PICC slipped 1.84% and 1.75%, respectively.

"On the first trading day after the September 7 announcement, the CSI Bank Index fell 1.46% and the insurance sector dropped over 2.40%. The core reason is that the good news was already priced in, so the announcement triggered profit-taking by investors who had positioned early," explains China Chengxin Analytics.

The pricing for the private placements at ICBC and ABC is set at no less than the 20-day average price. Dai Zhifeng, director of the research institute at Zhongtai Securities, believes that "major shareholders increasing stakes at or above market prices provides a floor for valuations rather than suppressing them."

Xu Ran, chief China financial analyst at Morgan Stanley, attributes the recent bank stock decline to substantial prior gains and consequent profit-taking. He notes that insurance companies, with better growth prospects, stand to benefit from this capital boost, which will solidify their role as patient capital and support the capital market's continued development.

By 4:00 PM on September 15, Wind data showed that A-share prices for ICBC and ABC had recovered to levels close to those seen on September 4, the trading day before the announcement. H-share prices, however, remained down over 2% and 3%, respectively, from that date. Among the four listed state-owned insurance groups, prices were lower compared to September 4, with China Life and PICC A-shares down 3.96% and 1.53%, respectively, and H-shares plus China Taiping and China Reinsurance Group seeing declines ranging from 4% to 7%.

Major state-owned banks are at the heart of this capital replenishment drive. On the afternoon of September 6, ICBC and ABC simultaneously announced plans to issue new A-shares to specific investors, with proceeds earmarked exclusively for boosting core Tier 1 capital. ICBC aims to raise up to 100 billion yuan, while ABC targets up to 160 billion yuan, with the Ministry of Finance subscribing for 70 billion yuan and 130 billion yuan, respectively, for a combined government contribution of 200 billion yuan.

As of September 6, the Ministry of Finance held 110.985 billion shares of ICBC, a 31.14% stake, and 123.515 billion A-shares of ABC, representing about 35.29%. Following the capital increases, these stakes are expected to rise further.

China National Tobacco Corporation and its affiliated entities have also signed conditional strategic cooperation agreements with both banks. Under these agreements, they will participate as strategic investors in the share issuances, with planned subscriptions totaling 30 billion yuan each, or 60 billion yuan combined. For ICBC, China Tobacco will subscribe for 10 billion yuan, while Shanghai Tobacco Group, Yunnan China Tobacco Industry, Hunan China Tobacco Industry, and China Tobacco Hunan Province Company will each subscribe for 5 billion yuan. The final amounts will be determined based on regulatory approvals of the fundraising scale.

For ABC, the plan shows China Tobacco subscribing for 10 billion yuan, with China Tobacco Jiangsu Province Company, China Tobacco Zhejiang Province Company, and China Tobacco Hubei Province Company each contributing 5 billion yuan, China Tobacco Beijing Province Company taking 3 billion yuan, and China Shuangwei Investment, a wholly-owned subsidiary of China Tobacco, subscribing for 2 billion yuan.

China Tobacco, a super-large state-owned enterprise approved by the State Council, operates autonomously in production and business activities. In 2025, the tobacco industry achieved combined industrial and commercial tax profits of 1.657 trillion yuan, up 3.5% year-on-year, and total fiscal contributions of 1.58 trillion yuan, up 2.3%, playing an irreplaceable role in national fiscal revenue. The company also has a history of investing in major financial institutions and holding those positions for the long term. This equity cooperation is expected to mobilize more long-term and patient capital to support a healthy and stable capital market. Previously, in Bank of Communications' 2025 private placement, China Tobacco and its subsidiaries participated with a combined subscription of 7.58 billion yuan.

The issuance prices for both banks' A-shares will be no lower than the average trading price over the 20 trading days preceding the pricing reference date, rounded to two decimal places. The number of shares issued will be determined by dividing the total fundraising amount by the issuance price. ICBC plans to issue no more than 10% of its existing total share capital, while ABC's issuance is capped at 15%. Both banks acknowledge that the issuance will improve capital adequacy and risk resilience, providing a solid capital base for business growth, but also carries the risk of diluting returns for existing shareholders in the near term.

ICBC's preliminary estimates suggest its core Tier 1 capital adequacy ratio will rise from 13.21% to 13.54% after the fundraising, while ABC projects an increase from 10.80% to 11.41%. In terms of dividend yields, Dai Zhifeng estimates that this round of fundraising will dilute ICBC's and ABC's dividend yields by 13 and 22 basis points, respectively, but the roughly 4% dividend yield levels for major banks remain essentially unchanged, preserving their appeal as high-dividend plays.

"With private placements subscribed by the Ministry of Finance and long-term tobacco system funds locked in for five years, there is no fundraising from the secondary market, no capital diversion, and no overhang from future share unlocks. Major shareholders increasing stakes at prices no lower than market levels provides a floor for valuations rather than suppressing them," Dai asserts.

Market sentiment toward this capital injection has been largely positive. Xue Huiru, a director at Fitch Ratings' Asia-Pacific financial institutions team, told a publication that the government's capital injection plan for state-owned banks underscores strong official support and helps mitigate the negative impact of certain pro-growth policies on bank profitability and capital levels. This, in turn, bolsters the banks' ability to serve the real economy and withstand internal and external shocks.

The Export-Import Bank of China will receive a 30 billion yuan injection from the Ministry of Finance. The bank stated that this will effectively consolidate its capital foundation, enhance its sustainable development confidence, and significantly boost its capacity to fund services for the real economy and opening-up initiatives while strengthening risk prevention capabilities.

"In the first half of the year, the Export-Import Bank has already issued nearly 650 billion yuan in new loans for foreign trade. The 30 billion yuan injection will directly expand its capital space, allowing for greater credit support to exports, the Belt and Road Initiative, and Chinese enterprises going global," according to China Chengxin Analytics.

Turning to the insurance sector, the long-rumored plan to inject capital into five state-owned insurance groups has finally been confirmed. On September 6, China Life Group, PICC, China Taiping, Sinosure, and China Reinsurance Group collectively disclosed that they will receive 70 billion yuan in total from the Ministry of Finance. This marks the first time the Ministry has used special treasury bond funds to inject capital into centrally-administered insurance enterprises.

Earlier, in March 2025, a source familiar with the matter indicated that the Ministry of Finance had been calculating since before the Spring Festival how to inject capital into state-owned insurers, with funds primarily intended for investment and capital market revitalization.

The injection methods and amounts vary across the five groups. The Ministry will directly inject 35 billion yuan into China Life Group and 7 billion yuan into China Taiping. PICC will issue A-shares to the Ministry of Finance as a specific investor, aiming to raise no more than 15 billion yuan. China Reinsurance Group will have the Ministry subscribe for domestic shares in cash, targeting 3 billion yuan.

The core rationale for these injections centers on strengthening capital to prevent risks, supporting the real economy, and driving high-quality development in core business operations.

As the largest life insurer, China Life Group is receiving the biggest single injection among insurance groups. The company announced that the Ministry of Finance will inject 35 billion yuan, a move aligned with central government directives to enhance financial services for the real economy and promote high-quality development of the financial and insurance sectors. This will further strengthen China Life's operational stability and risk resilience, injecting momentum into its focus on core business, governance improvement, and differentiated growth.

PICC announced a plan to issue A-shares to the Ministry of Finance, with proceeds capped at 15 billion yuan, all of which will go toward replenishing the company's capital base. This is expected to enhance PICC's stable operations and risk resilience.

China Taiping confirmed it will receive 7 billion yuan from the Ministry, a move designed to boost its risk-bearing capacity and promote balanced and stable key metrics such as solvency.

On September 6, China Reinsurance Group's board approved and disclosed a plan to issue domestic shares to the Ministry of Finance in cash, targeting 3 billion yuan, with all proceeds allocated to increasing its core Tier 1 capital. A company representative stated that the use of special treasury bonds for targeted capital injections into central financial enterprises reflects a strategic policy arrangement following central government directives. The company plans to leverage this issuance to enhance its reinsurance functions, boost high-quality development momentum, and elevate risk resilience.

As the sole state-owned policy insurer, Sinosure announced a 100 billion yuan injection from the Ministry of Finance. This capital supplement, carried out in a market-oriented and law-based manner, aims to improve the company's core Tier 1 capital, raise solvency adequacy ratios, and enhance its ability to fulfill policyholder obligations.

As early as May 7, 2025, at a State Council Information Office press conference, Li Yunze, then head of the National Financial Regulatory Administration, noted ongoing efforts to guide the industry toward cost reduction and sustainable development. He highlighted that capital replenishment mechanisms were being improved, with large commercial banks accelerating their capital enhancement work and large insurance groups' capital replenishment already on the agenda. Local governments were also exploring multiple channels to supplement capital for small and medium-sized financial institutions, all aimed at strengthening the financial system's resilience and capacity to support high-quality development.

Dong Ximiao, chief economist at Zhaolian, views this injection as a strong policy signal, demonstrating the government's firm commitment to reinforcing the capital strength of key financial institutions. This, he believes, will help stabilize insurance valuations and boost capital market confidence.

A seasoned market analyst notes that after a decline in insurance stocks during the first half of this year, their allocation value has emerged. The recent capital injections into five insurance groups, combined with expanding scale and capital bases, and the potential for market recovery in the second half of the year, could open up room for a rebound in insurance stocks.

Wind data through September 15's close shows that among insurance stocks tracked over 10 days, China Pacific Insurance, PICC, New China Life, Ping An Insurance, and China Life A-shares have fallen 1.33%, 2.28%, 6.29%, 4.15%, and 3.71%, respectively.

Market expectations for this capital injection round were well-established. In October 2024, the Ministry of Finance announced at a State Council Information Office press conference its intention to support large state-owned commercial banks in increasing core Tier 1 capital through special treasury bonds and other channels, following principles of coordination, phasing, and institution-specific approaches. The 2025 government work report proposed issuing 500 billion yuan in special treasury bonds for this purpose. In 2025, China Construction Bank, Bank of China, Bank of Communications, and Postal Savings Bank of China raised a combined 520 billion yuan through A-share private placements, with the Ministry of Finance subscribing for 500 billion yuan using special treasury funds. The 2026 government work report then proposed an additional 300 billion yuan in special treasury bonds for continued support.

Unlike previous rounds, this capital injection comes at a time when the major state-owned banks' capital levels remain adequate, making this more of a forward-looking arrangement. Hu Yuwei, chief policy analyst at China Securities, notes that as of the end of June 2026, the core Tier 1 capital adequacy ratios for the six major banks (ICBC, ABC, BOC, CCB, BOCOM, and PSBC) stood at 13.21%, 10.80%, 12.04%, 14.24%, 11.25%, and 10.04%, respectively, all well above regulatory requirements. Asset quality has also remained sound, with non-performing loan ratios ranging from 1.00% to 1.30%, with five of the six banks seeing improvements compared to end-2023 levels.

However, the banking sector's net interest margin has been steadily narrowing, falling from 2.08% at end-2021 to 1.41% in the first half of 2026, with the six major banks' margins ranging between 1.23% and 1.63%.

"The support from retained earnings for internal capital replenishment is weakening. Using special treasury bonds for external capital replenishment is a forward-looking arrangement to proactively strengthen risk resilience during a window of stable operations and sound asset quality," Hu explains.

Additionally, five of the major state-owned banks (ICBC, ABC, BOC, CCB, and BOCOM) are global systemically important banks (G-SIBs) subject to additional capital requirements. Fitch Bohua's report suggests that while some G-SIBs have already statically met the second-phase TLAC requirements for early 2028 as of end-June 2026, others still have a small gap to close. The government's continued use of scarce special treasury bond resources to inject capital into state-owned banks serves not only to build capital buffers for future support of the real economy and potential internal and external shocks but also as a prudent measure to help these institutions meet regulatory requirements on schedule.

The second batch of 300 billion yuan in special treasury bond injections differs from the first, covering state-owned banks, insurance groups, and policy banks. Of this, 40 billion yuan is allocated to Export-Import Bank of China and Sinosure. China Chengxin Analytics suggests that the significance of injecting capital into policy banks lies less in risk prevention and more in the state's willingness to back larger foreign trade credit and export insurance volumes with more capital, sending a clear signal to stabilize external demand amid heightened global trade uncertainty.

This round also marks the first time insurance has been incorporated into the special treasury bond injection framework, reflecting the growing systemic importance of insurance in the financial security landscape. An industry insider notes that after requirements for insurance funds to enter the market took effect, solvency pressures emerged for state-owned insurers. This capital injection will help improve solvency adequacy ratios, support stable operations, and enhance risk resilience.

The insurance sector faces three major capital pressures: First, persistently low long-term interest rates have pushed down the 750-day government bond yield curve, used as a benchmark for discounting life insurance reserves, forcing insurers to increase reserve provisions and passively consuming core capital. Second, starting in 2026, the transition period for the second phase of the "China Risk-Oriented Solvency System" officially ends, with stricter capital recognition and risk factors being fully applied. Third, insurers have been increasing allocations to equities and other risk assets, which carry the highest risk capital charges under the solvency framework.

According to data from the National Financial Regulatory Administration, as of the end of the first quarter of 2026, the insurance industry's core solvency adequacy ratio was 131.9% and the comprehensive solvency adequacy ratio was 181%. While these remain above regulatory red lines, they declined by 14.6 and 23.5 percentage points year-on-year, respectively. For life insurance companies, comprehensive and core solvency adequacy ratios fell by 25.9 and 14.7 percentage points, respectively.

Several senior industry figures characterize these injections as preventive capital replenishment for state-owned financial institutions. Ge Yuxiang, chief non-bank financial analyst at Zhongtai Securities, believes that this round of injections will, in the short term, alleviate the pressure on solvency from the declining 750-day curve, particularly on core solvency adequacy ratios. In the medium term, it addresses concerns over increased long-term equity investments in the stock market. In the long run, it enhances the capital strength and influence of state-owned commercial insurers within the industry. Looking ahead, these injections will enable major state-owned insurers to proactively manage potential solvency pressures under low interest rates and the capital consumption associated with regulatory encouragement to increase market participation.

Market observers are now focusing on the implications of this capital raising for the capital markets. China Securities predicts that this capital replenishment will "further open up equity allocation space" for the involved insurers. By boosting core capital and raising solvency adequacy ratios, insurers will be better positioned to expand long-term equity investments in a low-rate environment.

Wang Guojun argues that while loosening capital constraints expands the theoretical room for insurers' equity allocations, the theoretical ceiling doesn't translate directly into actual increases. Constraints such as liability costs, valuations, and performance assessments remain, with the benefits concentrated among leading state-owned insurers. The pace of entry into the market will not be a sharp surge but rather gradual and phased accumulation. Policy tailwinds won't fundamentally alter insurers' allocation style, which will continue to follow a "barbell" strategy, with high-dividend blue chips remaining the core foundation. Premium growth opportunities in hard tech, advanced manufacturing, and other quality growth sectors will see incremental enhancements.

With special treasury bond funds being channeled to policy banks and insurance groups, the fundraising scale for major state-owned banks has seen slight adjustments from initial expectations. "In the actual implementation, ABC's 160 billion yuan raise met expectations, but ICBC's 100 billion yuan came in below forecast," one market analyst notes. This could reflect ICBC's already-strong capital position and less urgent need for additional capital. The analyst also suggests that injecting capital into policy banks signals a desire for them to take on more policy-oriented functions.

Xu Ran adds that the reduced scale of capital injections for major state-owned banks reflects a shift in regulatory thinking toward promoting more rational credit growth.